Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-03

Clinical Trial Update: Maraviroc to Augment Rehabilitation Outcomes After Stroke [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating maraviroc to augment rehabilitation outcomes after stroke was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Maraviroc (maraviroc)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Stroke | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-08-03